20-F/A: Zepp Health Files Amendment to 20-F to Include Financials of Significant Equity Method Investee

Zepp Health Corporation files an amendment to its 2023 annual report to include the financial statements of Jiangsu Yitong High-tech Co., Ltd., a significant equity method investee.

Summary

• Zepp Health Corporation is filing Amendment No. 1 on Form 20-F/A to its annual report for the fiscal year ended December 31, 2023.
• The amendment is to comply with Regulation S-X, Rule 3-09, which requires separate financial statements for significant unconsolidated subsidiaries and investees accounted for by the equity method.
• The company has determined that its equity method investment in Jiangsu Yitong High-tech Co., Ltd. was significant under the investment test of Rule 1-02(w) of Regulation S-X.
• The amendment includes the financial statements and related notes of Jiangsu Yitong as of December 31, 2022 and 2023 and for the fiscal years ended December 31, 2021, 2022 and 2023.
• The filing also includes updated certifications from the CEO and CFO of Zepp Health Corporation and the consent of the independent auditor of Jiangsu Yitong.
• This amendment does not affect any other parts of, or exhibits to, the original filing.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment as it is a regulatory filing. The inclusion of Jiangsu Yitong's financials provides more information, but the impact on Zepp Health's overall performance requires further analysis.

Industry Context

The inclusion of Jiangsu Yitong's financials provides greater transparency into Zepp Health's investments and their impact on the company's overall financial performance, aligning with regulatory requirements for companies with significant equity method investments.

Comparison to Industry Standards

• It is difficult to compare Jiangsu Yitong to global benchmarks without knowing the specifics of their industry and competitive landscape.
• However, the inclusion of their financial statements allows investors to assess their performance against similar companies in the cable television network equipment, intelligent video monitoring, and chip/sensor industries.
• Companies like Hikvision (video surveillance) or semiconductor manufacturers could be considered for comparison, but a detailed analysis would be needed to draw meaningful conclusions.

Related Party Transactions

• For the year ended December 31, 2023, Jiangsu Yitong had sales to Anhui Huami of RMB 89,235 thousand.
• For the year ended December 31, 2023, Jiangsu Yitong purchased intangible assets from Hefei Huami.

Stakeholder Impact

• The inclusion of Jiangsu Yitong's financial statements provides more transparency for Zepp Health's shareholders.
• The amendment ensures compliance with SEC regulations, which benefits investors by providing a more complete financial picture.

Key Dates

Keywords

Zepp Health, Jiangsu Yitong, 20-F/A, Amendment, Financial Statements, Equity Method, Regulation S-X, SEC, Audit, Certifications